3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
172
Breast Neoplasms
24
Neoplasms
13
Leiomyoma
11
Polycystic Ovary Syndrome
5
Prostate Adenocarcinoma
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Adenocarcinoma
3
Salivary Gland Neoplasms
2
Rare Diseases
2
Myofibroma
2
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Hodgkin Disease
2
Breast Neoplasms, Male
2
Uveal Melanoma
1
Uterine Neoplasms
1
Urogenital Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Sleep Apnea, Obstructive
1
Skin Neoplasms
1
Skin Diseases
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Salivary Gland Neoplasm Duct
1
Respiratory Tract Diseases
1
Recurrence
1
Puberty, Precocious
1
Interventions
pembrolizumab
1
exemestane
1
Tamoxifen
1
Surgical Procedures, Operative
1
Leuprolide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Premenopausal Breast Cancer
×
Leuprolide
×
Clear all
NCT02990845
2023-02-22
PEER
National Taiwan University Hospital
Phase 1/2
Terminated
16 enrolled